Subtype
Uterine Neoplasm
CI-CAN-00004208Explore in graph →
Non-malignant925 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00004208Explore in graph →
Clinical trials
3,823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01061606 | Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus | terminated | Phase 2 | 8 | National Cancer Institute (NCI)NIH | 1 | Nov 9, 2016 | clinicaltrials |
| NCT00590967 | A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy | terminated | Phase 2 | 69 | Washington University School of MedicineOTHER | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01116245 | An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+(ADXS11-001) | terminated | Phase 2 | 81 | Advaxis, Inc.INDUSTRY | 1 | Jul 27, 2016 | clinicaltrials |
| NCT00671606 | Hysteroscopic Lymphatic Mapping for Endometrial Cancer | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | May 27, 2016 | clinicaltrials |
| NCT02479178 | A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck(iNSITE2) | terminated | Phase 2 | 73 | BIND TherapeuticsINDUSTRY | 2 | Apr 14, 2016 | clinicaltrials |
| NCT02042885 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer | terminated | Phase 1 / Phase 2 | 79 | Otsuka Novel Products GmbHINDUSTRY | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00966992 | Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer | terminated | Phase 2 | 3 | Washington University School of MedicineOTHER | 1 | Sep 9, 2015 | clinicaltrials |
| NCT01786226 | Mifepristone to Treat Uterine Fibroids | terminated | Phase 2 / Phase 3 | 220 | Mediterranea Medica S. L.OTHER | 1 | Sep 5, 2014 | clinicaltrials |
| NCT00958893 | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext | terminated | Phase 2 | 4 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 25, 2014 | clinicaltrials |
| NCT00470067 | Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer | terminated | Phase 2 | 9 | Roswell Park Cancer InstituteOTHER | 1 | Aug 22, 2014 | clinicaltrials |
| NCT00683917 | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids | terminated | Phase 2 | 10 | Repros Therapeutics Inc.INDUSTRY | 2 | Aug 21, 2014 | clinicaltrials |
| NCT00626561 | Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix | terminated | Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 7, 2014 | clinicaltrials |
| NCT01194609 | A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer | terminated | Phase 1 / Phase 2 | 2 | Korea Cancer Center HospitalOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00138151 | Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer | terminated | Phase 2 | 33 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00002478 | Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Jun 10, 2013 | clinicaltrials |
| NCT00003179 | Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer | terminated | Phase 2 | 360 | Gynecologic Oncology GroupNETWORK | 2 | Jun 10, 2013 | clinicaltrials |
| NCT00708942 | Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1 | terminated | Phase 2 | 83 | PhotocureINDUSTRY | 3 | Apr 24, 2013 | clinicaltrials |
| NCT00003624 | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 1 | Apr 11, 2013 | clinicaltrials |
| NCT00006224 | Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Apr 11, 2013 | clinicaltrials |
| NCT00006482 | Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Apr 11, 2013 | clinicaltrials |
| NCT00030472 | Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix | terminated | Phase 2 | — | Gynecologic Oncology GroupNETWORK | 2 | Apr 11, 2013 | clinicaltrials |
| NCT00002796 | Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer | terminated | Phase 1 / Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00052585 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer | terminated | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00231829 | A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | terminated | Phase 2 | 23 | Mark H. EinsteinOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00505492 | Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/Chemotherapy | terminated | Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 15, 2011 | clinicaltrials |
| NCT00782041 | Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer | terminated | Phase 2 | 11 | SanofiINDUSTRY | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00106262 | Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer | terminated | Phase 2 | 38 | Women and Infants Hospital of Rhode IslandOTHER | 1 | Apr 18, 2007 | clinicaltrials |
| NCT00220532 | Folate and Protection Against Cervical Cancer | terminated | Phase 1 / Phase 2 | 180 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Sep 13, 2006 | clinicaltrials |
Data updated 23 days agoSource updated Nov 9, 2016source: clinicaltrials